Cover Image
市場調查報告書

Edgemont Pharmaceuticals, LLC:產品平台分析

Edgemont Pharmaceuticals, LLC - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 293968
出版日期 內容資訊 英文 17 Pages
訂單完成後即時交付
價格
Back to Top
Edgemont Pharmaceuticals, LLC:產品平台分析 Edgemont Pharmaceuticals, LLC - Product Pipeline Review - 2014
出版日期: 2014年06月15日 內容資訊: 英文 17 Pages
簡介

本報告提供Edgemont Pharmaceuticals, LLC的治療藥開發平台現狀及各開發階段比較分析,彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Edgemont Pharmaceuticals, LLC的基本資料

Edgemont Pharmaceuticals, LLC概要

  • 主要資訊
  • 企業資料

Edgemont Pharmaceuticals, LLC:R&D概要

  • 主要的治療範圍

Edgemont Pharmaceuticals, LLC:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Edgemont Pharmaceuticals, LLC:開發中產品概況

Edgemont Pharmaceuticals, LLC:開發階段不明的開發中產品

  • 開發階段不明的產品/聯合治療模式

Edgemont Pharmaceuticals, LLC:藥物簡介

  • EDG-004
  • EDG-005
  • EDG-006
  • EDG-007
  • EDG-008

Edgemont Pharmaceuticals, LLC:總公司和子公司的所地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC05010CDB

Global Markets Direct's, 'Edgemont Pharmaceuticals, LLC - Product Pipeline Review - 2014', provides an overview of the Edgemont Pharmaceuticals, LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Edgemont Pharmaceuticals, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Edgemont Pharmaceuticals, LLC including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Edgemont Pharmaceuticals, LLC's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Edgemont Pharmaceuticals, LLC's pipeline products

Reasons to buy

  • Evaluate Edgemont Pharmaceuticals, LLC's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Edgemont Pharmaceuticals, LLC in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Edgemont Pharmaceuticals, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Edgemont Pharmaceuticals, LLC and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Edgemont Pharmaceuticals, LLC
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Edgemont Pharmaceuticals, LLC and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Edgemont Pharmaceuticals, LLC Snapshot
    • Edgemont Pharmaceuticals, LLC Overview
    • Key Information
    • Key Facts
  • Edgemont Pharmaceuticals, LLC - Research and Development Overview
    • Key Therapeutic Areas
  • Edgemont Pharmaceuticals, LLC - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Edgemont Pharmaceuticals, LLC - Pipeline Products Glance
    • Edgemont Pharmaceuticals, LLC - Unknown Stage Pipeline Products
      • Unknown Products/Combination Treatment Modalities
  • Edgemont Pharmaceuticals, LLC - Drug Profiles
    • EDG-004
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • EDG-005
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • EDG-006
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • EDG-007
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • EDG-008
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Edgemont Pharmaceuticals, LLC - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Edgemont Pharmaceuticals, LLC, Key Information
  • Edgemont Pharmaceuticals, LLC, Key Facts
  • Edgemont Pharmaceuticals, LLC - Pipeline by Indication, 2014
  • Edgemont Pharmaceuticals, LLC - Pipeline by Stage of Development, 2014
  • Edgemont Pharmaceuticals, LLC - Monotherapy Products in Pipeline, 2014
  • Edgemont Pharmaceuticals, LLC - Unknown, 2014

List of Figures

  • Edgemont Pharmaceuticals, LLC - Pipeline by Top 10 Indication, 2014
Back to Top